Verified earnings results
Neumora Therapeutics Q2 2026 Earnings Results
Neumora Therapeutics Q2 2026 reported revenue, operating income and net income.
Direct answer
Neumora Therapeutics reported Q2 2026 results on August 14, 2026.
Revenue was 0. EPS beat the estimate by 6.05%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Neumora Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- August 14, 2026
- Reported timing
- Before the US market opens
- EPS estimate
- -0.2448
- Reported EPS
- -0.23
- Revenue
- 0
- EPS surprise
- EPS beat the estimate by 6.05%.
Explore related company data
Read the frequently asked questions.
When did Neumora Therapeutics report Q2 2026 earnings?
Neumora Therapeutics reported on August 14, 2026. The reported timing was before the us market opens.
What is the available EPS estimate for Neumora Therapeutics?
The verified record provides an EPS estimate of -0.2448.
Has Neumora Therapeutics reported the Q2 2026 result?
Revenue was 0. EPS beat the estimate by 6.05%.
Which source supports this Neumora Therapeutics earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.